» Articles » PMID: 15887874

The Validity of Beck Depression Inventory and Hamilton Rating Scale for Depression Items in the Assessment of Depression Among Patients with Multiple Sclerosis

Overview
Journal J Behav Med
Specialty Social Sciences
Date 2005 May 13
PMID 15887874
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Measuring depression in patients with chronic illnesses such as multiple sclerosis (MS) is potentially complicated by the fact that several somatic symptoms of depression are also common in chronic illnesses. Whether standard assessment measures such as the Beck Depression Inventory (BDI) and Hamilton Rating Scale for Depression (HRSD) should exclude certain somatic symptoms when used in MS has been examined previously, but there is no clear consensus on this issue. The present study evaluated the utility of individual BDI and HRSD items for assessing depression in MS patients by examining how individual items responded to depression treatment in 42 (29 female) depressed MS patients. All 21 BDI items and 12 of 17 HRSD items decreased significantly with treatment, suggesting that all BDI items tap depression, as do 12 of 17 HRSD items. Thus, the present data support the inclusion of all BDI items when measuring depression in MS. Decisions on whether or not to use all HRSD items or only the 12 shown here to capture depression may depend on the study purpose and design.

Citing Articles

The Depression Prevalence in Chinese Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Huang J, Chen W, Zhu P Actas Esp Psiquiatr. 2024; 51(6):271-280.

PMID: 38321722 PMC: 10847664.


Clinical Practice Guidelines for the Detection and Treatment of Depression in Multiple Sclerosis: A Systematic Review.

McIntosh G, Liu E, Allan M, Grech L Neurol Clin Pract. 2023; 13(3):e200154.

PMID: 37124459 PMC: 10132261. DOI: 10.1212/CPJ.0000000000200154.


Impact of Multiple Sclerosis and Its Association with Depression: An Analytical Case-Control Investigation.

Ruiz-Sanchez F, Martins M, Soares S, Romero-Morales C, Lopez-Lopez D, Gomez-Salgado J Healthcare (Basel). 2022; 10(11).

PMID: 36360559 PMC: 9690715. DOI: 10.3390/healthcare10112218.


Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study).

Harnas S, Knoop H, Bennebroek Evertsz F, Booij S, Dekker J, van Laarhoven H Trials. 2021; 22(1):696.

PMID: 34641961 PMC: 8507219. DOI: 10.1186/s13063-021-05657-z.


Antidepressant Effects of a Persian Medicine Remedy on Multiple Sclerosis Patients: A Double-Blinded Randomized Clinical Trial.

Adalat M, Khalili M, Ayromlou H, Haririan S, Bagher Fazljou S, Rezaeizadeh H Galen Med J. 2021; 8:e1212.

PMID: 34466472 PMC: 8343653. DOI: 10.31661/gmj.v8i0.1212.


References
1.
Minden S, Orav J, Reich P . Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987; 9(6):426-34. DOI: 10.1016/0163-8343(87)90052-1. View

2.
Joffe R, Lippert G, Gray T, Sawa G, Horvath Z . Mood disorder and multiple sclerosis. Arch Neurol. 1987; 44(4):376-8. DOI: 10.1001/archneur.1987.00520160018007. View

3.
Geisser M, Roth R, Robinson M . Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. 1997; 13(2):163-70. DOI: 10.1097/00002508-199706000-00011. View

4.
Aikens J, Reinecke M, Pliskin N, Fischer J, Wiebe J, McCracken L . Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory?. J Behav Med. 1999; 22(2):127-42. DOI: 10.1023/a:1018731415172. View

5.
Gilchrist A, Creed F . Depression, cognitive impairment and social stress in multiple sclerosis. J Psychosom Res. 1994; 38(3):193-201. DOI: 10.1016/0022-3999(94)90115-5. View